Lauren Davis
Medical · Charleston, SCNPI 1962737684
Payments from drug & device makers
Across 174 payments — averaging $22.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$824
- GSK$597
- Mallinckrodt Hospital Products Inc.$449
- Sanofi$314
- Boehringer Ingelheim$205
- Genentech USA, Inc.$194
- plus $1K from 24 others
What the payments were for
- Food & beverage$3,70895%
- Education$2125%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 39 | $824 |
| GSK | 24 | $597 |
| Mallinckrodt Hospital Products Inc. | 12 | $449 |
| Sanofi | 14 | $314 |
| Boehringer Ingelheim | 6 | $205 |
| Genentech USA, Inc. | 9 | $194 |
| CSL Behring | 7 | $173 |
| Electromed, Inc. | 13 | $153 |
| Regeneron Healthcare Solutions, Inc. | 4 | $105 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $92 |
| Gilead | 4 | $90 |
| Novartis | 4 | $88 |
| Amgen | 4 | $83 |
| Harmony Biosciences LLC | 3 | $72 |
| Insmed, Inc. | 3 | $68 |
| Mylan Specialty L.p. | 3 | $53 |
| Grifols USA, LLC | 3 | $49 |
| Actelion Pharmaceuticals US, Inc. | 3 | $46 |
| United Therapeutics Corporation | 2 | $38 |
| Merck | 2 | $33 |
| Teva Pharmaceuticals USA, Inc. | 2 | $26 |
| Vapotherm Inc | 1 | $24 |
| Pharming Healthcare, Inc. | 1 | $23 |
| Sunovion Pharmaceuticals Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $19 |
| AbbVie | 1 | $18 |
| Apria Healthcare LLC | 1 | $14 |
| Resmed Corp | 1 | $13 |
| Philips North America LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$106
How this compares
$3,919 in reported general payments places this provider in the 80th percentile of 384 medical providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 16 | $201,695 |
| Dupixent PenDupilumab | 14 | $48,424 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $373 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimOfev | $205 | $201,69516 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 384 medical providers in South Carolina.
Other medical in Charleston
- Mary MacdonaldCharleston$20K
- Eliza HoughCharleston$13K
- Jennifer HayesCharleston$12K
- Hannah GlaabCharleston$12K
- Meredith GriffinCharleston$11K
- Lindsey VollonoCharleston$10K
- Brett DalmauCharleston$9K
- Brooke PlewinskiCharleston$8K
- Jessica BrownCharleston$8K
- Heather CheekCharleston$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.